/
2 GATE: 2 GATE:

2 GATE: - PowerPoint Presentation

calandra-battersby
calandra-battersby . @calandra-battersby
Follow
438 views
Uploaded On 2016-08-15

2 GATE: - PPT Presentation

Graphic Appraisal Tool for Epidemiology 1991 2015 3 1 picture 2 formulas amp 3 acronyms GATE Graphic Appraisal Tool for Epidemiology Graphic Architectural Tool for Epidemiology ID: 448157

gate amp cancer outcomes amp gate outcomes cancer study picture population measured smokers group formulas acronyms comparison exposure occurrence ego allocated aged

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "2 GATE:" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1
Slide2

2Slide3

GATE:

Graphic Appraisal Tool for Epidemiology

1991 - 2015

3

1 picture, 2 formulas & 3 acronymsSlide4

GATE:

Graphic Appraisal Tool for

Epidemiology

Graphic

Architectural Tool

for

Epidemiology

Graphic

Approach To Epidemiology

making epidemiology accessible

4Slide5

4

th

year medical students 1991Slide6

Jerry Morris

n

umerator denominator

epidemiology =

In: Uses of Epidemiology 1977

6Slide7
Slide8

p

resentation outline

GATE is a framework for:

study design

study analysis

study error

practicing EBM

8

1 picture, 2 formulas & 3 acronymsSlide9

1Slide10

GATE: a framework for study design

1 picture

10

every epidemiological

study can be hung on the GATE frame

1

picture

, 2 formulas & 3 acronymsSlide11

cohort

of British doctors

non-smokers

smokers

lung cancer events counted

yes

no

followed

for 10 years

smoking status allocated by measurement

(

observation)

cohort

/

longitudinal

/

follow-up study

11

1

picture: GATE frame

1

picture

, 2 formulas & 3 acronymsSlide12

British doctors

placebo

aspirin

MI

yes

no

5 years

r

andomly allocated to aspirin or placebo

12

1

st

acronym: PECOT

Participants

Comparison

Exposure

Outcomes

Time

P

E

C

O

T

r

andomised controlled trial

1 picture, 2 formulas & 3

acronymsSlide13

m

iddle-aged Americans

‘normal’ weight

overweight

d

iabetes status measured in all participants

yes

no

b

ody mass index measured

c

ross-sectional (prevalence) study

13

P

E

C

O

TSlide14

m

iddle-aged American women

b

reast cancer

m

ammogram negative

yes

no

receive mammogram screening test

d

iagnostic

test (prediction) study

m

ammogram positive

14

P

E

C

O

TSlide15

m

iddle-aged American women

m

ammogram

test

no breast cancer

positive

negative

Gold Standard

d

iagnostic (test accuracy) study

b

reast cancer

15

P

E

C

O

TSlide16

non-smokers

smokers

l

ung cancer

yes

no

smoking status measured

c

ase-control study

16

P

E

C

O

T

cases

controls

(all nested in virtual cohort studies)Slide17

£100Slide18

2Slide19

GATE: a framework for study analysis:

1

st

formula: occurrence = outcomes ÷ population

19

the numbers in epidemiological studies can be hung on the GATE frame

1 picture, 2

formulas

& 3 acronymsSlide20

British doctors

non-smokers

smokers

Lung cancer

yes

no

10 years

smoking status measured

20

1

st

formula

: occurrence of outcomes =

n

umber of outcomes ÷ number in population/group

Participant Population

Comparison Group

Exposure Group

Outcomes

Time

P

EG

CG

O

T

a

bSlide21

British doctors

non-smokers

smokers

Lung cancer

yes

no

10 years

smoking status measured

21

Population

Comparison Group

Exposure Group

Outcomes

Time

P

EG

CG

O

T

Exposure Group Occurrence (EGO) = a

÷

EG

= number of outcomes (a) ÷ number in exposed population (EG)

a

bSlide22

British doctors

placebo

aspirin

MI

yes

no

5

years

r

andomly allocated

22

Population

Comparison Group

Exposure Group

Outcomes

Time

P

EG

CG

O

T

a

b

Comparison Group Occurrence (CGO) = b

÷

CG

= number of outcomes (

b

) ÷ number in comparison population (CG)Slide23

yes

no

23

E

pidemiology =

N

umerator ÷

D

enominator

Participant Population

Comparison Group

Exposure Group

Outcomes

Time

P

EG

D

O

T

a

N

m

iddle-aged American women

b

reast cancer

m

ammogram negative

receive mammogram screening test

m

ammogram positiveSlide24

British doctors

non-smokers

smokers

Lung cancer

yes

no

10 years

smoking status measured

24

t

he goal of all epidemiological studies is to calculate

EGO and CGO

P

EG

CG

O

T

a

b

EGO:

Occurrence (risk) of cancer in smokers

C

GO:

Occurrence of cancer in non-smokersSlide25

Middle-aged Americans

Low BMI

High BMI

EGO:

Average blood glucose in EG

high

low

Body Mass Index (BMI) measured

25

P

EG

CG

O

C

GO:

Average blood glucose in CGSlide26

Middle-aged Americans

Low BMI

High BMI

b

lood glucose

high

low

Body Mass Index (BMI) measured

c

ross-sectional study with numerical measures

26

P

E

C

O

TSlide27

Middle-aged American women

mammogram

no Breast cancer

positive

negative

Gold Standard

Breast cancer

27

P

E

C

O

T

EGO:

likelihood of a positive mammogram if breast cancer

C

GO:

likelihood of a positive mammogram if no breast cancerSlide28

EGO ÷ CGO

= Relative

Risk (RR

)

EGO – CGO

= Risk Difference

(RD)

i

ts all about EGO and CGO

measures of occurrence

: risk; rate; likelihood; probability; average; incidence; prevalence

28

1

st

formula:

occurrence

= outcomes ÷ populationSlide29

3Slide30

GATE: framework

for

nonrandom error

2

nd

acronym: RAMBOMAN

30

R

ecruitment

A

llocation

M

aintenance

B

lind

O

bjective

M

easurements

AN

alyses

1 picture, 2 formulas & 3

acronymsSlide31

R

AMBOMAN

Recruitment of participants

‘who

are the findings

applicable to?’

P

P

Study setting

Eligible population

31

r

ecruitment process Slide32

EG CG

O

T

RCT: a

llocated by

randomisation

(

e.g

to drugs

)

EG CG

O

T

Cohort: a

llocated

by measurement

(e.g. smoking)

R

A

MBOMAN:

were participants well

Allocated

to exposure & comparison groups?’

EG & CG similar at baseline?

w

as

Allocation

to EG & CG successful?

32

E & C measures accurate?Slide33

RA

M

BOMAN

EG CG

O

T

‘were Participants well

Maintained

in the groups they were allocated to?’

P

completeness

of follow-up

c

ompliance

c

ontamination

c

o

-

interventions

33Slide34

RAM

B

O

M

AN

EG

CG

O

T

‘were

outcomes

well

Measured

?’

w

ere they measured

Blind

to whether participant was in EG or CG

?

P

34Slide35

RAMB

OM

AN

EG

CG

O

T

‘were

outcomes

well

Measured

?’

w

ere they measured

Objectively

?

P

35Slide36

RAMBOM

AN

EG

C

CG

C

O

T

P

36

EG

A

CG

A

a

b

‘were the

ANalyses

done well

?’

If RCT were

I

ntention

T

o

T

reat (ITT)

analyses done?Slide37

RAMBOM

AN

EG CG

O

T

‘were the

ANalyses

done well

?’

P

a

djustment for baseline differences / confounding?

37Slide38

GATE

:

random error:

2

nd

formula:

random error = 95% confidence interval

38

There is about a 95% chance that the true

value in

the underlying

population

lies

within

the 95% CI (assuming no non-random error)

EGO ± 95% CI

C

GO ± 95% CI

1 picture, 2

formulas

& 3 acronyms

s

ample from a population Slide39

GATE

:

a framework for error in systematic reviews & meta-analyses:

3

rd

acronym: FAITH

1 picture, 2 formulas & 3

acronyms

39Slide40

 

study sources

s

tudies appraised & allocated:

included

excluded

s

tudies summarised

& pooled if homogeneous

systematic review: a study

of studies

studies

screened

40Slide41

 

study sources

s

tudies appraised & allocated:

included

excluded

s

tudies summarised

& pooled if homogeneous

studies

screened

critical appraisal of SR:

FAITH

Find

Appraise

Include

Total

H

eterogeneity?

1 picture, 2

formulas

& 3 acronyms

41Slide42

4Slide43

GATE: framework for the 4 steps of EBP

43Slide44

t

he steps of EBP:

A

sk

Acquire

3. Appraise

4. Apply & Act

44Slide45

yes

no

45

1. Participants

3. Comparison

2. Exposure

4. Outcomes

5. Time

P

E

C

O

T

EBP Step 1:

ASK

- turn your question into

a focused 5-part PECOT question Slide46

EBP Step

2:

ACQUIRE

the evidence – use

PE

COT

to help choose search terms

46

yes

no

Participants

Comparison

Exposure

Outcomes

Time

P

E

C

O

TSlide47

P

E

C

O

T

P

E

C

O

T

R

ecruitment

A

llocation

M

aintenance

b

lind

o

bjective

M

easurements

AN

alyses

47

EBP Step 3:

APPRAISE

the evidence – with the picture, acronyms & formulas

Occurrence = outcomes ÷ population

Random error = 95% Confidence Interval Slide48

APPLY

the evidence by AMALGAMATING the

relevant information &

making

an

evidence-based decision:’

the X-factor

©

48Slide49

49Slide50

e

pidemiological evidence

p

atient’s clinical circumstances

s

ystem features

v

alues & preferences

X-factor: making evidence-based decisions

Practitioner

e

X

pertise

: ‘putting it all together’

- the

art of practice

e

conomic

legal

political

person

family

community

practitioner

social

p

hysical health

psychological

Clinical expertise in the era of evidence-based medicine and patient choice. EBM 2002;736-8 (March/April)

50Slide51

GATE critically appraised topic (CATs) formsSlide52

GATE CAT –

4-

sheet workbook (in Excel)

sheet 1: GATE-Ask &

Acquire

52Slide53

53

GATE CAT – 3-sheet workbook (in Excel)

sheet 2: GATE-Appraise

(with calculator)Slide54

54

GATE CAT – 3-sheet workbook (in Excel)

sheet 3: GATE-ApplySlide55
Slide56
Slide57

57